FDA approves a second Alzheimer’s drug that can modestly slow disease
https://abcnews.go.com/Health/wireStory/fda-approves-alzheimers-drug-modestly-slow-disease-111619103
FDA approves a second Alzheimer’s drug that can modestly slow disease
https://abcnews.go.com/Health/wireStory/fda-approves-alzheimers-drug-modestly-slow-disease-111619103
2 Comments
The FDA approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second that’s been convincingly shown to delay cognitive decline in patients, following last year’s approval of a similar from Japanese drugmaker Eisai. This will help bring forward more ways to combat Alzheimer’s and hopefully eventually a full cure for it in the future
“The delay seen with both drugs amounts to a matter of months — about seven months, in the case of Lilly’s drug. Patients and their families will have to weigh that benefit against the downsides, including regular IV infusions and potentially dangerous side effects like brain swelling.”
Side effects seem a bit too much for slowing 7 months your cognitive decline.